Therapeutic effects of bone marrow mesenchymal stem cells via modulation of TLR2 and TLR4 on renal ischemia-reperfusion injury in male Sprague-Dawley rats
BioImpacts · 08.07.2020 · 11 (3) · 219-226
DOI: 10.34172/bi.2021.31 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioImpacts, online erschienen am 08.07.2020. Verfasst von Zeinab Karimi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Nephro-Urology Research Center (SNURC), Shiraz University of Medical Sciences, Shiraz, Iran. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Acute kidney injury (AKI) induced by renal ischemia-reperfusion (I/R) injury is a pro-inflammatory process that activates toll-like receptors (TLRs). Stem cell therapy holds a great promise for kidney repair. Therefore, we investigated the immunomodulatory role of bone marrow stromal cells (BMSCs) on TLR2 and TLR4 expression in AKI in male Sprague-Dawley rats.
Methods
BMSCs were isolated from the bone marrow of male rats, cultured in DMEM, and characterized using appropriate markers before transplantation. Renal I/R was induced by 45 minutes bilateral ischemia followed by 24 hours of reperfusion. Rats received intraperitoneal injections of BMSCs (1.5 × 106 cells, i.p, per rat) immediately after termination of renal ischemia. Serum samples were collected pre-and post-stem cells injection for assessment of blood urea nitrogen (BUN) and creatinine (Cr) levels. The kidneys were harvested after 24 hours of reperfusion for structural and molecular analysis.
Results
Renal I/R caused severe tissue injuries and increased the level of BUN (166.5 ± 12.9 vs. 18.25 ± 1.75) and Cr (3.7 ± 0.22 vs. 0.87 ± 0.06) compared to the sham group. In addition, mRNA expression of TLR2 and TLR4 elevated in the renal I/R group. Administration of BMSCs improved the functional and structural state of the kidney induced by I/R and down-regulated TLR2 and TLR4 gene expression.
Conclusion
The results showed a highly significant renoprotection by BMSCs that indicates their therapeutic potential in I/R injures. These effects are most likely associated with the TLR2/4 signaling pathway via modulation of the inflammatory response cascades.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shiraz Nephro-Urology Research Center (SNURC), Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Anatomical Sciences, Faculty of Medicine, Hormozgan University of Medical Sciences, Hormozgan, Iran.
- Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Zeinab Karimi, Seyedeh-Sara Hashemi
Zitieren
APA
Karimi, Z., Janfeshan, S., Kargar Abarghouei, E., & Hashemi, S. S. (2020). Therapeutic effects of bone marrow mesenchymal stem cells via modulation of TLR2 and TLR4 on renal ischemia-reperfusion injury in male Sprague-Dawley rats. BioImpacts, 11(3), 219-226. https://doi.org/10.34172/bi.2021.31
Vancouver
Karimi Z, Janfeshan S, Kargar Abarghouei E, Hashemi SS. Therapeutic effects of bone marrow mesenchymal stem cells via modulation of TLR2 and TLR4 on renal ischemia-reperfusion injury in male Sprague-Dawley rats. BioImpacts. 2020;11(3):219-226. doi:10.34172/bi.2021.31
BibTeX
@article{Karimi2020,
author = {Karimi, Zeinab and Janfeshan, Sahar and Kargar Abarghouei, Elias and Hashemi, Seyedeh-Sara},
title = {Therapeutic effects of bone marrow mesenchymal stem cells via modulation of TLR2 and TLR4 on renal ischemia-reperfusion injury in male Sprague-Dawley rats},
journal = {BioImpacts},
year = {2020},
volume = {11},
number = {3},
pages = {219--226},
doi = {10.34172/bi.2021.31}
}
EUVIMED